Constitutively activated STAT3 has been demonstrated to be essential for the proliferation and survival of DLBCL cells, which provides a prognostic indicator and ideal target for DLBCL treatment [6,7]. Here, STAT3 is linked to diffuse large B-cell lymphoma.